Unauthorized health products recall in Canada: May pose serious health risks
In plain language
This recall involves several unauthorized health products seized from Tokyo Beauty and Healthcare stores in Richmond, B.C. They are being recalled because they contain prescription, controlled, or over-the-counter drugs not approved for sale in Canada. These products have not been assessed for safety, efficacy, or quality and may pose serious health risks. Stop using the products and follow the return steps in the official notice.
What to do
- Stop using the products immediately.
- Return the products to your local pharmacy for proper disposal.
- Consult a healthcare professional if you have used any of these products and have health concerns.
- If you suspect an opioid overdose from Pabron Gold A Granules Cold Medication, call 911 and administer naloxone if available.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Serious health risks due to unauthorized drug ingredients
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Serious health risks due to unauthorized drug ingredients
What should consumers do?
Stop using the products immediately. Return the products to your local pharmacy for proper disposal. Consult a healthcare professional if you have used any of these products and have health concerns. If you suspect an opioid overdose from Pabron Gold A Granules Cold Medication, call 911 and administer naloxone if available.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Serious health risks due to unauthorized drug ingredients
When was this product recalled?
This product was recalled on March 8, 2024.